In particular, appropriate screening (i.e., with ultrasound, non‐invasive cross‐sectional abdominal imaging or alpha fetoprotein [AFP] marker testing) is underutilized for patients at risk of HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.